Medical research
New nanoparticle combination therapy shows effective resuscitation for massive hemorrhage
Massive hemorrhage, or excessive bleeding, is a potentially preventable yet a major cause of death in trauma patients.
Jul 30, 2019
0
0
Page 27 - News tagged with combination
Medications
Enzalutamide shows survival benefit in men with metastatic prostate cancer
A combination of enzalutamide and androgen deprivation therapy (ADT) significantly reduced the risk of metastatic progression or death over time in men with advanced prostate cancer, according to the results of clinical trial ...
Jul 30, 2019
0
12
Oncology & Cancer
Gene test picks out prostate cancers that could respond to 'search-and-destroy' medicine
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports.
Jul 23, 2019
0
3
Medications
Cancer biologists identify new drug combo
When it comes to killing cancer cells, two drugs are often better than one. Some drug combinations offer a one-two punch that kills cells more effectively, requires lower doses of each drug, and can help to prevent drug resistance.
Jul 11, 2019
0
70
Medications
Xpovio with dexamethasone approved for refractory multiple myeloma
Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.
Jul 10, 2019
0
0
Oncology & Cancer
Treatment target pinpointed for liver cancer in teens and young adults
New findings show how a genetically aberrant, fused protein promotes a rare form of liver cancer in adolescents and young adults. The researchers also saw that a certain mix of drugs could target the fused protein and the ...
Jul 9, 2019
0
0
Oncology & Cancer
Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations
The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase ...
Jul 6, 2019
0
2
Diseases, Conditions, Syndromes
Combination therapy for rosacea shows improved response rates
Combining ivermectin cream (IVM) and doxycycline modified-release capsules (DMR) can improve response rates for patients with severe rosacea, according to a study recently published in the Journal of the American Academy ...
Jun 27, 2019
0
2
Oncology & Cancer
Adding targeted therapy to treatment extends lives of those with metastatic breast cancer
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the ...
Jun 3, 2019
0
2
Oncology & Cancer
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients
Ibrutinib and venetoclax, two FDA-approved drugs for treating chronic lymphocytic leukemia (CLL), have been shown to be effective when given together for high-risk and older patients with the disease, according to a study ...
May 29, 2019
0
14
